Cargando…

‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation

BACKGROUND: Oncology patients have tremendous symptom burden both physically and emotionally. Palliative care (PC) improves quality of life and prevents suffering. Advance care planning (ACP) empowers patients to articulate goals of their care. New guidelines call for palliative care to be provided...

Descripción completa

Detalles Bibliográficos
Autor principal: Davis, Jessica Tamar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558017/
https://www.ncbi.nlm.nih.gov/pubmed/37808072
http://dx.doi.org/10.6004/jadpro.2023.14.6.3
_version_ 1785117195490033664
author Davis, Jessica Tamar
author_facet Davis, Jessica Tamar
author_sort Davis, Jessica Tamar
collection PubMed
description BACKGROUND: Oncology patients have tremendous symptom burden both physically and emotionally. Palliative care (PC) improves quality of life and prevents suffering. Advance care planning (ACP) empowers patients to articulate goals of their care. New guidelines call for palliative care to be provided and chemotherapy avoided the last 2 weeks of life. The American Society of Clinical Oncology (ASCO) recommends integrating palliative care within the oncology setting to achieve these outcomes. However, the best mode to provide this care remains unclear. A nurse practitioner/physician assistant (NP/PA)-based model from within the oncology clinic is a potential option. METHODS: A program evaluation was done to determine the effectiveness of the “My Choices, My Wishes” NP/PA-led program. RESULTS: From 2012 to 2018, the number of patients receiving PC/ACP visits increased from 2.6% to 19.4%. The percentage of patients receiving chemotherapy in the last 14 days of life decreased from 12.5% to 7.14%. The number of advance care directives completed increased from 17.5% to 37.5%. CONCLUSION: This program was an effective way to provide PC/ACP for oncology patients. We still need to understand why patients pursue chemotherapy at the end of life. It is necessary to improve our communication techniques with patients and families in order to guarantee high-quality, high-value care.
format Online
Article
Text
id pubmed-10558017
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-105580172023-10-07 ‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation Davis, Jessica Tamar J Adv Pract Oncol Research & Scholarship BACKGROUND: Oncology patients have tremendous symptom burden both physically and emotionally. Palliative care (PC) improves quality of life and prevents suffering. Advance care planning (ACP) empowers patients to articulate goals of their care. New guidelines call for palliative care to be provided and chemotherapy avoided the last 2 weeks of life. The American Society of Clinical Oncology (ASCO) recommends integrating palliative care within the oncology setting to achieve these outcomes. However, the best mode to provide this care remains unclear. A nurse practitioner/physician assistant (NP/PA)-based model from within the oncology clinic is a potential option. METHODS: A program evaluation was done to determine the effectiveness of the “My Choices, My Wishes” NP/PA-led program. RESULTS: From 2012 to 2018, the number of patients receiving PC/ACP visits increased from 2.6% to 19.4%. The percentage of patients receiving chemotherapy in the last 14 days of life decreased from 12.5% to 7.14%. The number of advance care directives completed increased from 17.5% to 37.5%. CONCLUSION: This program was an effective way to provide PC/ACP for oncology patients. We still need to understand why patients pursue chemotherapy at the end of life. It is necessary to improve our communication techniques with patients and families in order to guarantee high-quality, high-value care. Harborside Press LLC 2023-09 2023-09-01 /pmc/articles/PMC10558017/ /pubmed/37808072 http://dx.doi.org/10.6004/jadpro.2023.14.6.3 Text en © 2023 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research & Scholarship
Davis, Jessica Tamar
‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation
title ‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation
title_full ‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation
title_fullStr ‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation
title_full_unstemmed ‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation
title_short ‘My Choices, My Wishes' Program and Its Effect on Chemotherapy at the End of Life and Advance Care Directive Documentation
title_sort ‘my choices, my wishes' program and its effect on chemotherapy at the end of life and advance care directive documentation
topic Research & Scholarship
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558017/
https://www.ncbi.nlm.nih.gov/pubmed/37808072
http://dx.doi.org/10.6004/jadpro.2023.14.6.3
work_keys_str_mv AT davisjessicatamar mychoicesmywishesprogramanditseffectonchemotherapyattheendoflifeandadvancecaredirectivedocumentation